Literature DB >> 1159831

Neoplasms in persons treated with x-rays in infancy: fourth survey in 20 years.

L H Hempelmann, W J Hall, M Phillips, R A Cooper, W R Ames.   

Abstract

The incidence of neoplastic disease was determined by a mail survey of 2,872 young adults given X-ray treatments in infancy and of their 5,005 nonirradiated siblings. Newly diagnosed benign and malignant neoplasms appeared more frequently in the irradiated subjects than in their siblings or the age- and sex-matched general population of upstate New York. Only thyroid neoplasms occurred in sufficient numbers to permit statistical analysis for the effects on incidence of sex, age, and dose, and of being in a high-risk group (sub-group C). Thyroid cancers developed earlier in life than did benign neoplasms, especially in boys; benign goiters occurred after smaller doses, predominantly in females. Females had a greater risk of developing thyroid cancer than males--2,3 times for females of all ages and 5 times for young adults. Except for young adult females, there was no definite age effect. The risk of cancer (but not of benign goiter) was proportional to the thyroid dose, with a linear risk coefficient of 2.5/year/million people exposed to 1 rad for the entire irradiated population and 4.0 for subgroup C. The high risk of thyroid cancer in subgroup C may be the result of the high percentage of Jews, who had a 3.4-fold greater risk than non-Jews. Young adult Jewish females had a 17-fold increased risk. An incidental observation was an apparent increased incidence of asthma and rare diseases with abnormal immunologic features in the irradiated population.

Entities:  

Mesh:

Year:  1975        PMID: 1159831     DOI: 10.1093/jnci/55.3.519

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  25 in total

1.  Insights from radiation treatment for benign disease.

Authors:  N M Bleehen
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-29

2.  Radiation hazards in a paediatric intensive care unit.

Authors:  A Werner; J M Isdale
Journal:  Pediatr Radiol       Date:  1986

3.  Second malignant neoplasms in Hodgkin's disease.

Authors:  E P Getaz
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort.

Authors:  Michael Jacob Adams; Roy E Shore; Ann Dozier; Steven E Lipshultz; Ronald G Schwartz; Louis S Constine; Thomas A Pearson; Marilyn Stovall; Kelly Thevenet-Morrison; Susan G Fisher
Journal:  Radiat Res       Date:  2010-10-26       Impact factor: 2.841

5.  A clinical evaluation of radiation-induced hyperparathyroidism based on 148 surgically treated patients.

Authors:  I Hedman; G Hansson; L M Lundberg; L E Tisell
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

Review 6.  Carcinogenic risk in diagnostic nuclear medicine: biological and epidemiological considerations.

Authors:  F Overbeek; E K Pauwels; J J Broerse
Journal:  Eur J Nucl Med       Date:  1994-09

7.  Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.

Authors:  M Jacob Adams; Ann Dozier; Roy E Shore; Steven E Lipshultz; Ronald G Schwartz; Louis S Constine; Thomas A Pearson; Marilyn Stovall; Paul Winters; Susan G Fisher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

8.  Thyroid tumors associated with radiation exposure.

Authors:  C Silverman
Journal:  Public Health Rep       Date:  1984 Jul-Aug       Impact factor: 2.792

9.  The epidemiology of thyroid cancer in Los Angeles county.

Authors:  S Preston-Martin; H R Menck
Journal:  West J Med       Date:  1979-11

10.  A differential nuclear uptake and retention of 3H-androgens in the thyroids of baboons.

Authors:  P J Sheridan; T B Aufdemorte; R G Triplett; G Holt; P M Martin
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.